Gontinias, Jelian F.

HRN: 10-73-32  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/15/2022
08/21/2022
IVTT
200mg
Q8 For 7 Days
Amoebiasis
Waiting Final Action 
08/15/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
08/15/2022
08/21/2022
ORAL
7.5ml
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: